Neurology and Therapy

Scope & Guideline

Advancing Neurological Health Through Open Access Research

Introduction

Immerse yourself in the scholarly insights of Neurology and Therapy with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2193-8253
PublisherSPRINGER LONDON LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2012 to 2024
AbbreviationNEUROL THER / Neurol. Ther.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND

Aims and Scopes

The journal "Neurology and Therapy" is dedicated to advancing the understanding and treatment of neurological disorders through innovative research and clinical studies. The journal covers a broad spectrum of topics related to neurology, emphasizing patient-centered approaches, therapeutic interventions, and the integration of novel methodologies in clinical practice.
  1. Neurological Disorders and Treatments:
    The journal focuses on a wide range of neurological conditions including Alzheimer's disease, multiple sclerosis, Parkinson's disease, epilepsy, and migraine, with a commitment to exploring both pharmacological and non-pharmacological treatments.
  2. Patient-Centric Research:
    A significant emphasis is placed on understanding patient experiences, treatment preferences, and quality of life. Research often incorporates qualitative methods to gauge patient perspectives on their conditions and treatments.
  3. Innovative Therapeutic Approaches:
    The journal highlights advancements in treatment modalities, including novel drug therapies, biologics, and emerging technologies such as deep brain stimulation and virtual reality interventions.
  4. Real-World Evidence and Clinical Practice:
    Research published often includes real-world studies and meta-analyses that assess the effectiveness and safety of treatments in diverse patient populations, thereby bridging the gap between clinical trials and everyday clinical practice.
  5. Biomarkers and Diagnostic Tools:
    The journal explores the development and application of biomarkers and diagnostic methods that aid in the early detection and management of neurological disorders, enhancing personalized treatment strategies.
The landscape of research within "Neurology and Therapy" is evolving, with several themes gaining traction in recent years. This section highlights the emerging scopes that reflect current trends and future directions in neurological research.
  1. Real-World Evidence and Patient Outcomes:
    There is a growing trend towards studies that utilize real-world data to assess the effectiveness and safety of treatments, emphasizing the importance of patient outcomes and experiences in clinical decision-making.
  2. Telehealth and Digital Therapeutics:
    The rise of telehealth and digital therapeutic interventions has become a focal point, particularly in the context of the COVID-19 pandemic, as researchers explore their efficacy in managing neurological conditions.
  3. Personalized Medicine and Biomarkers:
    Research focusing on personalized medicine, particularly the use of biomarkers to tailor treatments to individual patient profiles, is increasingly prominent, reflecting advancements in genetic and molecular research.
  4. Multimodal Approaches to Treatment:
    An emerging trend is the exploration of multimodal treatment strategies that combine pharmacological, behavioral, and rehabilitation therapies, aiming for a more holistic approach to patient care.
  5. Neuroinflammation and Neurodegeneration Research:
    There is a notable increase in studies investigating the role of neuroinflammation in various neurological disorders, as researchers seek to uncover new therapeutic targets and mechanisms.

Declining or Waning

While "Neurology and Therapy" continues to thrive in numerous research areas, certain themes have shown a decline in frequency or prominence in recent publications. These waning scopes may reflect shifting research priorities or advancements in alternative therapeutic strategies.
  1. Traditional Pharmacotherapy for Chronic Conditions:
    There is a noticeable reduction in studies focusing solely on traditional pharmacological approaches to chronic neurological conditions, as the field increasingly embraces combination therapies and integrative treatment models.
  2. Basic Science Research:
    Research articles centered on basic science or purely mechanistic studies are becoming less frequent, possibly due to a shift in focus towards clinical applications and real-world effectiveness.
  3. Longitudinal Studies:
    The prevalence of longitudinal studies examining the long-term outcomes of treatments appears to be decreasing, potentially replaced by more immediate efficacy studies or innovative trial designs.
  4. Conventional Rehabilitation Approaches:
    There is a decline in publications focused on conventional rehabilitation methods, as newer technologies and therapeutic approaches (like virtual reality) gain traction in the field.
  5. Epidemiological Studies of Rare Neurological Disorders:
    Research on rare neurological disorders has seen a decrease, possibly due to the challenges in recruiting large cohorts and the increasing focus on more prevalent conditions or conditions with broader impact.

Similar Journals

npj Parkinsons Disease

Fostering collaboration for a deeper understanding of Parkinson's.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Parkinsons Disease is a leading open-access journal dedicated to advancing research in the field of Parkinson's disease and related neurodegenerative disorders. Published by NATURE PORTFOLIO, this journal has been on the forefront of scientific inquiry since its inception in 2015, providing a high-quality platform for the dissemination of groundbreaking research. The journal's reputation is underscored by its impressive Q1 rankings in Cellular and Molecular Neuroscience and Neurology categories, as well as its commendable positions in Scopus rankings, placing it within the top echelons of neuroscience and clinical neurology research. With its focus on innovative methodologies and translational studies, npj Parkinsons Disease aims to foster collaboration among researchers, clinicians, and healthcare professionals, ultimately contributing to the improved understanding and treatment of Parkinson's disease. Researchers, professionals, and students are encouraged to explore its rich repository of knowledge, accessible freely since its launch, to stay abreast of the latest developments in this critical area of neuroscience.

Progress in Neurology and Psychiatry

Advancing knowledge in neurology and psychiatry.
Publisher: JOHN WILEY & SONS LTDISSN: 1367-7543Frequency: 4 issues/year

Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.

Annals of Indian Academy of Neurology

Championing High-Quality Research in Indian Neurology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Journal of Movement Disorders

Innovating research for better movement health.
Publisher: KOREAN MOVEMENT DISORDERS SOCISSN: 2005-940XFrequency: 3 issues/year

The Journal of Movement Disorders, published by the Korean Movement Disorders Society, is a premier open access journal dedicated to advancing the field of neurology with a specific focus on movement disorders. Established in 2008 and indexed with ISSN 2005-940X and E-ISSN 2093-4939, this journal plays a vital role in disseminating high-quality research and clinical insights to a global audience. With an impressive Q2 ranking in both Neurology and Clinical Neurology categories for 2023, the journal continues to feature innovative research articles that contribute to better understanding and management of various movement disorders. Ranked 104th out of 400 in Clinical Neurology and 54th out of 192 in Neuroscience, the Journal of Movement Disorders offers an essential platform for researchers, healthcare professionals, and students alike, fostering collaboration and knowledge exchange in a rapidly evolving field.

LANCET NEUROLOGY

Your Gateway to Neurology's Cutting Edge
Publisher: ELSEVIER SCIENCE INCISSN: 1474-4422Frequency: 12 issues/year

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.

Multiple Sclerosis Journal-Experimental Translational and Clinical

Innovating Insights in Neurology and Neuroscience
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Multiple Sclerosis Journal-Experimental Translational and Clinical, published by SAGE Publications, Inc., is an essential open-access platform since 2015 dedicated to advancing research in the field of multiple sclerosis and related neurological disorders. With an ISSN of N/A and an E-ISSN of 2055-2173, the journal aims to bridge the gap between experimental studies and clinical applications, offering valuable insights into cellular and molecular neuroscience as well as clinical neurology. The journal holds a reputable Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) for 2023, indicating its significant contribution to these fields. Positioned at the intersection of scientific discovery and clinical practice, the Multiple Sclerosis Journal serves as an indispensable resource for researchers, clinicians, and students dedicated to improving outcomes for individuals affected by multiple sclerosis and related disorders. With a Scopus ranking of #163/400 in Medicine - Neurology and #67/97 in Neuroscience, this journal continues to play a pivotal role in shaping the future of neurological research and therapy.

Current Journal of Neurology

Exploring the complexities of the brain and beyond.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

PARKINSONISM & RELATED DISORDERS

Connecting research with real-world impact.
Publisher: ELSEVIER SCI LTDISSN: 1353-8020Frequency: 12 issues/year

PARKINSONISM & RELATED DISORDERS, published by Elsevier Science Ltd, is a prominent peer-reviewed journal dedicated to advancing the understanding of Parkinson's disease and related neurodegenerative disorders. With an impact factor placing it in the Q2 category across multiple fields including Geriatrics and Gerontology and Neurology for 2023, this journal serves as a crucial platform for researchers, healthcare professionals, and students alike. Covering an array of topics from clinical trials to innovative therapeutic strategies, it aims to disseminate valuable insights that can improve patient care and outcomes. While it remains a subscription-based journal, its relevance is underscored by its consistent rankings in Scopus, where it ranks 105th in Clinical Neurology and 35th in Geriatrics and Gerontology. Authored by top scholars in the field, PARKINSONISM & RELATED DISORDERS continues to contribute significantly to the body of knowledge surrounding these debilitating conditions, facilitating the exchange of cutting-edge research and fostering collaboration within the scientific community.

Multiple Sclerosis International

Unlocking insights, improving outcomes in MS and beyond.
Publisher: HINDAWI LTDISSN: 2090-2654Frequency:

Multiple Sclerosis International is a leading open-access journal dedicated to advancing the scientific understanding of multiple sclerosis (MS) and related neurological disorders. Published by HINDAWI LTD since 2010, this journal serves as a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality peer-reviewed articles that cover a diverse range of topics, including epidemiology, treatment strategies, and the latest advancements in MS research. With its commitment to open access, Multiple Sclerosis International ensures that critical findings are readily available to the global community, fostering collaborative efforts to improve patient outcomes and advance therapeutic approaches. The journal not only enhances scholarly discourse in the field but also significantly impacts clinical practices by presenting cutting-edge research and insights.

Aktualnosci Neurologiczne

Bridging Research and Practice in Neurology
Publisher: MEDICAL COMMUNICATIONSISSN: 1641-9227Frequency: 4 issues/year

Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.